N-[(1-benzyl-2-oxo-indol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide
TL;DR: N-[(1-benzyl-2-oxo-indol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide (CAS 372970-65-5) is a chemical compound with molecular formula C26H24N4O4 and molecular weight 456.18 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
N-(1-benzyl-2-hydroxyindol-3-yl)imino-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide
Also Known As: N-[(1-benzyl-2-oxo-indol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide, N-[(1-benzyl-2-oxoindol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide, (Z)-N-(2-(2-(1-benzyl-2-oxoindolin-3-ylidene)hydrazinyl)-2-oxoethyl)-2-(p-tolyloxy)acetamide, N-[(E)-(1-benzyl-2-oxoindol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide, N-[(Z)-(1-benzyl-2-oxoindol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide
| Molecular Formula | C26H24N4O4 |
|---|---|
| Molecular Weight | 456.18 g/mol |
| LogP | 4.50912 |
| Topological Polar Surface Area | 105.28 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Exact Mass | 456.17975 |
| Heavy Atoms | 34 |
| Complexity | 1328.4368 |
Chemical Identifiers
| CAS Number | 372970-65-5 |
|---|---|
| SMILES | CC1=CC=C(C=C1)OCC(=O)NCC(=O)N=NC2=C(N(C3=CC=CC=C32)CC4=CC=CC=C4)O |
Product Overview
N-[(1-benzyl-2-oxo-indol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide (CAS 372970-65-5), with molecular formula C26H24N4O4 and molecular weight 456.18 g/mol. IUPAC: N-(1-benzyl-2-hydroxyindol-3-yl)imino-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide.
Chemical Property Profile of N-[(1-benzyl-2-oxo-indol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide
Property Insights of N-[(1-benzyl-2-oxo-indol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide
The XLogP value of 4.50912 indicates that N-[(1-benzyl-2-oxo-indol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 105.28 Ų falls within the moderate polarity range, balancing permeability and solubility for N-[(1-benzyl-2-oxo-indol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide. Following Lipinski's Rule of Five, N-[(1-benzyl-2-oxo-indol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide has 2 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of N-[(1-benzyl-2-oxo-indol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide?
The CAS number of N-[(1-benzyl-2-oxo-indol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide is 372970-65-5.
What is the molecular formula of N-[(1-benzyl-2-oxo-indol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide?
The molecular formula of N-[(1-benzyl-2-oxo-indol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide is C26H24N4O4.
What is the molecular weight of N-[(1-benzyl-2-oxo-indol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide?
The molecular weight of N-[(1-benzyl-2-oxo-indol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide is 456.18 g/mol.
Where can I buy N-[(1-benzyl-2-oxo-indol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide?
You can request a quote for N-[(1-benzyl-2-oxo-indol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for N-[(1-benzyl-2-oxo-indol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide?
Yes, KEHONG BIO provides custom synthesis services for N-[(1-benzyl-2-oxo-indol-3-ylidene)amino]-2-[[2-(4-methylphenoxy)acetyl]amino]acetamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.